4 Steps for Improved Excision Coding

Part 2: Consider skin lesion type, location, and excised diameter.

Consideration of several factors, such as the type of removal, lesion size and location, pathologic results, intent, etc., are key to accurately coding dermatological lesion removal procedures. Let’s review the codes and guidelines for lesion removal by excision and how to avoid common mistakes when coding these skin procedures.

Editor’s note: This article is the second part of a three-part series based on the presentation given by Melissa Caperton, RHIA, CPC, CPMA, CPPM, CFPC, Approved Instructor, at HEALTHCON 2019. We began this series last month by breaking down the complexities of skin procedure coding in the article “Explore in Depth the Complexities of Skin Procedures.”

Excision – Benign/Malignant Lesions (11400-11646)

Excision involves the cutting and full-thickness removal of a lesion, with extension through the dermis into the subcutis. Skin lesion excisions include the surrounding tissue or margins. To accurately code lesion excisions, review the documentation for details regarding whether the lesion is benign or malignant, the location, and the excised diameter.

Code selection is determined by the size of the excision.

1  Check the pathology report.

Skin excision codes are first classified based on information extracted from the pathology report on whether the lesion is benign (non-cancerous) or malignant (cancerous). Do not code the lesion type based on “suspected” or “probable.” Base your code selection on the pathology report, even if it means waiting a few days before submitting the claim.
If the report describes a benign lesion or one of uncertain behavior (for example, indications of atypia or dysplasia), assign a benign lesion code (11400-11446).
If pathology confirms malignancy, assign a malignant lesion code (11600-11646). Malignancies can be further classified into:

• Carcinoma in-situ – precancerous cells that have not spread beyond the primary site; may evolve into an invasive malignancy
• Primary site – the original, or first, tumor in the body growing at the anatomical site where tumor progression began
• Secondary (metastatic) site – cancer cells that have spread from the primary site to other parts of the body and formed secondary tumors

Without a pathology report to confirm the diagnosis, you must assign an unspecified diagnosis and a benign lesion excision code (11400-11471).

2  Location matters.

Knowing whether the lesion was benign or malignant will help you select the code that also identifies the anatomic location from which the lesion was excised.
Benign lesion

Trunk, arms, legs – 11400-11406

Scalp, neck, hands, feet, genitalia – 11420-11426

Face, ears, eyelids, nose, lips, mucous membrane – 11440-11446

Malignant lesion

Trunk, arms, legs – 11600-11606

Scalp, neck, hands, feet, genitalia – 11620-11626

Face, ears, eyelids (skin only), nose, lips – 11640-11646

3  Calculate excision size.

Code selection is determined by the size of the excision, not the size of the lesion. Excision size includes the size of the lesion plus the width of the excised margins (the area surrounding the lesion that is also removed). To calculate the excision size, measure the diameter of the lesion at its longest point (greatest clinical diameter) plus two times the narrowest margin appropriate for removing the entire lesion (the margin on both sides of the lesion).
Note: The rule of thumb is to measure first; cut second. The provider should measure the lesion and margins preoperatively because the lesion tissue generally changes shape or shrinks once removed and placed in formalin.

4  Consider the circumstances.

Before you code, make sure to evaluate for the presence of special circumstances such as removal of multiple lesions, re-excision, and bundling concerns.

• Report each lesion separately; multiple excisions require a modifier. When the provider removes multiple lesions in a single visit, code each lesion separately, assigning specific CPT® and ICD-10-CM codes for every lesion treated, and report the most complex lesion first. Append modifier 59 Distinct procedural service to the second and all subsequent codes describing lesion excision in the same anatomic location.
• Re-excision necessitates special consideration. The provider may revisit a previous excision to remove additional tissue if pathology shows malignancy in the margins. Proper reporting of this re-excision depends on the timing of the follow-up excision.

If re-excision is performed during the same session as the initial excision, report one code based on the final widest margin. This should describe the greatest area removed. For example, if the first excision measures 2.0 cm with margins, and the second excision increases the margins by 1.0 cm on all sides, code for a 4.0 cm excision. Do not report a 2.0 cm excision and a 4.0 cm excision.

If the re-excision is performed during a subsequent session, code based on the diameter of the new excision and append modifier 58 Staged or related procedure or service by the same physician during the postoperative period because the re-excision occurred during the global period of the initial excision.

• Be on the lookout for bundling issues. According to CPT® guidelines, all lesion excision codes include local anesthesia and simple wound closure. Repair by intermediate or complex closure should be reported separately.

In such cases, report intermediate (12031-12057) and complex (13100-13153) repairs or reconstructive closure (15002-15261, 15570-15770) in addition to lesion excision (11440-11446). Note, however, payers who follow the National Correct Coding Initiative (NCCI) edits will bundle intermediate and complex repairs into excision of benign lesions of 0.5 cm or less (11400, 11420, and 11440).
Next month, in the final installment of this three-part series, we’ll review coding tips for wound repair (closure) procedures.

• Author
• Recent Posts

Stacy Chaplain

Stacy Chaplain, MD, CPC, is an executive editor at AAPC. She has worked in medicine for almost 20 years and has more than five years' experience in medical writing & editing. Prior to AAPC, she led a compliance team as director of clinical coding quality for a multispecialty group practice. Chaplain received her Bachelor of Arts in Biology from The University of Texas at Austin and her Medical Doctorate from The University of Texas Medical Branch in Galveston. She is a member of the Beaverton, Ore. local chapter.

Latest posts by Stacy Chaplain (see all)

• Hernia Repair Coding Made Easy - March 1, 2021
• Reporting Eli Lilly’s Antibody Combo Therapy - February 26, 2021
• AAPC & AHLA Collaborative Compliance Conference Wrap-Up: Day 2 - February 24, 2021